This inventor holds 1 USPTO granted patent. Top assignee: The United States of America as Represented by the Department of Health. Active years: 1995.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1995
Title: Eugenia Viu and Her Patent on Cognitive Treatment
Introduction
Eugenia Viu is an inventor associated with Barcelona, Spain. Her patent work concerns potential treatments for cognitive impairment and neurological conditions.
Latest Patents
Viu is credited with 1 patent, titled “Treating Cognition with Aminocyclopropanecarboxylic Derivatives.” The patent describes using compounds that act at the NMDA receptor complex’s strychnine-insensitive glycine site to improve cognition in healthy people and address cognitive deficits associated with neuronal degeneration, brain injury, hypoxia, and other neurological disorders. The compounds discussed include 1-aminocyclopropanecarboxylic acid and specified pharmaceutically acceptable forms, as well as 7-chlorokynurenic acid and its specified derivatives.
Career Highlights
The patent lists The United States of America as Represented by the Department of Health as the assignee. Its subject matter reflects research into pharmacological approaches to cognition and neurological disorders.
Collaborations
Phil Skolnick and Ramon Trullas are identified as Viu’s coworkers in connection with the supplied information.
Conclusion
Eugenia Viu’s patent documents an approach to treating cognitive deficits through compounds acting on the NMDA receptor complex, with the U.S. Department of Health listed as assignee.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
